CCR5 deficiency increased susceptibility to lipopolysaccharide-induced acute renal injury

Archives of Toxicology

Volumn 90, Issue 5, 2016, Pages 1151-1162

  Lee, Dong Hun ^a   Park, Mi Hee ^a   Hwang, Chul Ju ^a   Hwang, Jae Yeon ^a   Yoon, Hae Suk ^a   Yoon, Do Young ^b   Hong, Jin Tae ^a  

^a Chungbuk National University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Acute kidney injury; CCR5; Cytokine; MAP kinase

Indexed keywords

CASPASE 3; CHEMOKINE RECEPTOR CCR5; CREATININE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BIOLOGICAL MARKER; CCR5 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; KIDNEY CELL; MACROPHAGE; MORTALITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPTIC SHOCK; SIGNAL TRANSDUCTION; UREA NITROGEN BLOOD LEVEL; WILD TYPE; ANIMAL; BLOOD; CELL CULTURE; CHEMICALLY INDUCED; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENETIC PREDISPOSITION; GENETICS; KIDNEY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHENOTYPE; TIME FACTOR;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; BIOMARKERS; BLOOD UREA NITROGEN; CELLS, CULTURED; CREATININE; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; INFLAMMATION MEDIATORS; KIDNEY; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; RECEPTORS, CCR5; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84930606586     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-015-1530-9     Document Type: Article

References (51)

1. Akcay A, Nguyen Q, Edelstein CL (2009) Mediators of inflammation in acute kidney injury. Mediat Inflamm 2009:137072. doi:10.1155/2009/137072
2. Albelda SM, Smith CW, Ward PA (1994) Adhesion molecules and inflammatory injury. FASEB J 8(8):504–512
3. Anders HJ, Vielhauer V, Frink M et al (2002) A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Invest 109(2):251–259. doi:10.1172/JCI14040
4. Barcellos LF, Schito AM, Rimmler JB et al (2000) CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple sclerosis genetics group. Immunogenetics 51(4–5):281–288
5. Broide DH, Humber D, Sullivan S, Sriramarao P (1998) Inhibition of eosinophil rolling and recruitment in P-selectin- and intracellular adhesion molecule-1-deficient mice. Blood 91(8):2847–2856
6. Coenen M, Nattermann J (2010) The role of CCR5 in HCV infection. Eur J Med Res 15(3):97–101
7. Cunningham PN, Dyanov HM, Park P, Wang J, Newell KA, Quigg RJ (2002) Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 168(11):5817–5823
8. Cunningham PN, Wang Y, Guo R, He G, Quigg RJ (2004) Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J Immunol 172(4):2629–2635
9. Dawson TC, Beck MA, Kuziel WA, Henderson F, Maeda N (2000) Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 156(6):1951–1959. doi:10.1016/S0002-9440(10)65068-7
10. Day YJ, Huang L, Ye H, Linden J, Okusa MD (2005) Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am J Physiol Renal Physiol 288(4):F722–F731. doi:10.1152/ajprenal.00378.2004
11. Dong Z, Atherton SS (2007) Tumor necrosis factor-alpha in cisplatin nephrotoxicity: a homebred foe? Kidney Int 72(1):5–7. doi:10.1038/sj.ki.5002320
12. Fadel SA, Bromley SK, Medoff BD, Luster AD (2008) CXCR3-deficiency protects influenza-infected CCR5-deficient mice from mortality. Eur J Immunol 38(12):3376–3387. doi:10.1002/eji.200838628
13. Fantuzzi G, Zheng H, Faggioni R et al (1996) Effect of endotoxin in IL-1 beta-deficient mice. J Immunol 157(1):291–296
14. Fattori E, Della Rocca C, Costa P et al (1994) Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. Blood 83(9):2570–2579
15. Faubel S, Ljubanovic D, Reznikov L, Somerset H, Dinarello CA, Edelstein CL (2004) Caspase-1-deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis. Kidney Int 66(6):2202–2213. doi:10.1111/j.1523-1755.2004.66010.x
16. Furuichi K, Wada T, Iwata Y et al (2003) CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J Am Soc Nephrol 14(10):2503–2515
17. Furuichi K, Gao JL, Horuk R, Wada T, Kaneko S, Murphy PM (2008) Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury. J Immunol 181(12):8670–8676
18. Gadient RA, Patterson PH (1999) Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury. Stem Cells 17(3):127–137. doi:10.1002/stem.170127
19. Homsi E, Ribeiro-Alves MA, Lopes de Faria JB, Dias EP (2002) Interleukin-6 stimulates tubular regeneration in rats with glycerol-induced acute renal failure. Nephron 92(1):192–199
20. Jo SK, Cho WY, Sung SA, Kim HK, Won NH (2005) MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney Int 67(2):458–466. doi:10.1111/j.1523-1755.2005.67102.x
21. Kayama F, Yoshida T, Elwell MR, Luster MI (1995) Cadmium-induced renal damage and proinflammatory cytokines: possible role of IL-6 in tubular epithelial cell regeneration. Toxicol Appl Pharmacol 134(1):26–34. doi:10.1006/taap.1995.1165
22. Kelly KJ, Williams WW Jr, Colvin RB, Bonventre JV (1994) Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci U S A 91(2):812–816
23. Knotek M, Rogachev B, Wang W et al (2001) Endotoxemic renal failure in mice: role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int 59(6):2243–2249. doi:10.1046/j.1523-1755.2001.00740.x
24. Lee YK, Kwak DH, Oh KW et al (2009) CCR5 deficiency induces astrocyte activation, Abeta deposit and impaired memory function. Neurobiol Learn Mem 92(3):356–363. doi:10.1016/j.nlm.2009.04.003
25. Li L, Huang L, Sung SS et al (2007) NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury. J Immunol 178(9):5899–5911
26. Linas SL, Shanley PF, Whittenburg D, Berger E, Repine JE (1988) Neutrophils accentuate ischemia-reperfusion injury in isolated perfused rat kidneys. Am J Physiol 255(4 Pt 2):F728–F735
27. Mehta RL, Kellum JA, Shah SV et al (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11(2):R31. doi:10.1186/cc5713
28. Meldrum KK, Meldrum DR, Hile KL et al (2001) p38 MAPK mediates renal tubular cell TNF-alpha production and TNF-alpha-dependent apoptosis during simulated ischemia. Am J Physiol Cell Physiol 281(2):C563–C570
29. Messmer UK, Briner VA, Pfeilschifter J (1999) Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int 55(6):2322–2337. doi:10.1046/j.1523-1755.1999.00473.x
30. Mishima K, Baba A, Matsuo M, Itoh Y, Oishi R (2006) Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity. Free Radic Biol Med 40(9):1564–1577. doi:10.1016/j.freeradbiomed.2005.12.025
31. Moreno C, Gustot T, Nicaise C et al (2005) CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice. Hepatology 42(4):854–862. doi:10.1002/hep.20865
32. Patel NS, Chatterjee PK, Di Paola R et al (2005) Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion. J Pharmacol Exp Ther 312(3):1170–1178. doi:10.1124/jpet.104.078659
33. Perez de Lema G, Maier H, Franz TJ et al (2005) Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. J Am Soc Nephrol 16(12):3592–3601. doi:10.1681/ASN.2005040426
34. Ramesh G, Reeves WB (2002) TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110(6):835–842. doi:10.1172/JCI15606
35. Ramesh G, Reeves WB (2003) TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 285(4):F610–F618. doi:10.1152/ajprenal.00101.2003
36. Ramesh G, Reeves WB (2005) p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am J Physiol Renal Physiol 289(1):F166–F174. doi:10.1152/ajprenal.00401.2004
37. Ramesh G, Kimball SR, Jefferson LS, Reeves WB (2007) Endotoxin and cisplatin synergistically stimulate TNF-alpha production by renal epithelial cells. Am J Physiol Renal Physiol 292(2):F812–F819. doi:10.1152/ajprenal.00277.2006
38. Remick DG, Newcomb DE, Bolgos GL, Call DR (2000) Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13(2):110–116
39. Russell JA, Singer J, Bernard GR et al (2000) Changing pattern of organ dysfunction in early human sepsis is related to mortality. Crit Care Med 28(10):3405–3411
40. Rybak SL, Murphy RF (1998) Primary cell cultures from murine kidney and heart differ in endosomal pH. J Cell Physiol 176(1):216–222. doi:10.1002/(SICI)1097-4652(199807)176:1<216:AID-JCP23>3.0.CO
41. Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M (1996) Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 35(11):3362–3367. doi:10.1021/bi952950g
42. Schrier RW, Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351(2):159–169. doi:10.1056/NEJMra032401351/2/159
43. Segerer S, Nelson PJ, Schlondorff D (2000) Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 11(1):152–176
44. Segerer S, Banas B, Wornle M et al (2004) CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am J Pathol 164(2):635–649. doi:10.1016/S0002-9440(10)63152-5
45. Sorce S, Bonnefont J, Julien S et al (2010) Increased brain damage after ischaemic stroke in mice lacking the chemokine receptor CCR5. Br J Pharmacol 160(2):311–321. doi:10.1111/j.1476-5381.2010.00697.x
46. Turner JE, Paust HJ, Steinmetz OM et al (2008) CCR5 deficiency aggravates crescentic glomerulonephritis in mice. J Immunol 181(9):6546–6556
47. Turner JE, Paust HJ, Bennstein SB et al (2012) Protective role for CCR5 in murine lupus nephritis. Am J Physiol Renal Physiol 302(11):F1503–F1515. doi:10.1152/ajprenal.00382.2011
48. Wang W, Faubel S, Ljubanovic D et al (2005) Endotoxemic acute renal failure is attenuated in caspase-1-deficient mice. Am J Physiol Renal Physiol 288(5):F997–F1004. doi:10.1152/ajprenal.00130.2004
49. Xu C, Chang A, Hack BK, Eadon MT, Alper SL, Cunningham PN (2014) TNF-mediated damage to glomerular endothelium is an important determinant of acute kidney injury in sepsis. Kidney Int 85(1):72–81. doi:10.1038/ki.2013.286
50. Yanaba K, Mukaida N, Matsushima K, Murphy PM, Takehara K, Sato S (2004) Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production. Eur J Immunol 34(12):3553–3561. doi:10.1002/eji.200425426
51. Zhang D, Li Y, Liu Y, Xiang X, Dong Z (2013) Paclitaxel ameliorates lipopolysaccharide-induced kidney injury by binding myeloid differentiation protein-2 to block Toll-like receptor 4-mediated nuclear factor-kappaB activation and cytokine production. J Pharmacol Exp Ther 345(1):69–75. doi:10.1124/jpet.112.202481